Siren LLC’s Gossamer Bio GOSS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$857K Hold
5,208,968
0.02% 114
2026
Q1
$1.71M Hold
5,208,968
0.05% 91
2025
Q4
$16.1M Hold
5,208,968
0.48% 42
2025
Q3
$13.7M Hold
5,208,968
0.54% 42
2025
Q2
$6.41M Hold
5,208,968
0.33% 52
2025
Q1
$5.73M Hold
5,208,968
0.32% 53
2024
Q4
$4.71M Sell
5,208,968
-8,072,642
-61% -$6.92M 0.21% 65
2024
Q3
$13.1M Buy
+13,281,610
New +$12.8M 0.65% 39

Other funds holding GOSS

Siren LLC's GOSS Position: Q2 2026 in Review

Siren LLC held its Gossamer Bio (GOSS) position steady in Q2 2026 at 5,208,968 shares worth $857K. The position accounts for 0.02% of the portfolio, ranked #114.

Siren LLC first reported a position in GOSS in Q3 2024 and has held it in 8 quarters since. The position peaked at $16.1M in Q4 2025. 170 funds tracked by Wall St. Rank hold GOSS as of Q2 2026.

  • Siren LLC held 5,208,968 shares of Gossamer Bio worth $857K as of Q2 2026.
  • Siren LLC left its Gossamer Bio share count unchanged in Q2 2026.
  • Gossamer Bio made up 0.02% of Siren LLC's portfolio in Q2 2026, its #114 holding.
  • Siren LLC first reported a position in Gossamer Bio in Q3 2024 and has held it in 8 quarters since.
  • Siren LLC's Gossamer Bio position peaked at $16.1M in Q4 2025.
  • 170 funds tracked by Wall St. Rank held Gossamer Bio as of Q2 2026.

Based on Siren LLC's 13F filing for Q2 2026, filed 13 Aug 2026.